These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 23707769)

  • 21. Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
    Mirams GR; Cui Y; Sher A; Fink M; Cooper J; Heath BM; McMahon NC; Gavaghan DJ; Noble D
    Cardiovasc Res; 2011 Jul; 91(1):53-61. PubMed ID: 21300721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel.
    Ridley JM; Milnes JT; Hancox JC; Witchel HJ
    J Mol Cell Cardiol; 2006 Jan; 40(1):107-18. PubMed ID: 16288909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clemizole hydrochloride blocks cardiac potassium currents stably expressed in HEK 293 cells.
    Jie LJ; Wu WY; Li G; Xiao GS; Zhang S; Li GR; Wang Y
    Br J Pharmacol; 2017 Feb; 174(3):254-266. PubMed ID: 27886373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bupivacaine destabilizes action potential duration in cellular and computational models of long QT syndrome 1.
    Schwoerer AP; Zenouzi R; Ehmke H; Friederich P
    Anesth Analg; 2011 Dec; 113(6):1365-73. PubMed ID: 22003215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of HERG K+ current and prolongation of the guinea-pig ventricular action potential by 4-aminopyridine.
    Ridley JM; Milnes JT; Zhang YH; Witchel HJ; Hancox JC
    J Physiol; 2003 Jun; 549(Pt 3):667-72. PubMed ID: 12740430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel.
    Crumb WJ; Vicente J; Johannesen L; Strauss DG
    J Pharmacol Toxicol Methods; 2016; 81():251-62. PubMed ID: 27060526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
    Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
    Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct block of hERG potassium channels by the protein kinase C inhibitor bisindolylmaleimide I (GF109203X).
    Thomas D; Hammerling BC; Wimmer AB; Wu K; Ficker E; Kuryshev YA; Scherer D; Kiehn J; Katus HA; Schoels W; Karle CA
    Cardiovasc Res; 2004 Dec; 64(3):467-76. PubMed ID: 15537500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human ether-a-go-go-related gene K+ channel and IKr of guinea pig cardiomyocytes by antipsychotic drug trifluoperazine.
    Choi SY; Koh YS; Jo SH
    J Pharmacol Exp Ther; 2005 May; 313(2):888-95. PubMed ID: 15722405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine.
    Staudacher I; Wang L; Wan X; Obers S; Wenzel W; Tristram F; Koschny R; Staudacher K; Kisselbach J; Koelsch P; Schweizer PA; Katus HA; Ficker E; Thomas D
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Feb; 383(2):119-39. PubMed ID: 21120454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute effects of oestrogen on the guinea pig and human IKr channels and drug-induced prolongation of cardiac repolarization.
    Kurokawa J; Tamagawa M; Harada N; Honda S; Bai CX; Nakaya H; Furukawa T
    J Physiol; 2008 Jun; 586(12):2961-73. PubMed ID: 18440994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 degrees C: Cisapride versus dofetilide.
    Milnes JT; Witchel HJ; Leaney JL; Leishman DJ; Hancox JC
    J Pharmacol Toxicol Methods; 2010; 61(2):178-91. PubMed ID: 20172036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
    Thomas D; Karle CA; Kiehn J
    Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channel.
    Schmalhofer WA; Swensen AM; Thomas BS; Felix JP; Haedo RJ; Solly K; Kiss L; Kaczorowski GJ; Garcia ML
    Assay Drug Dev Technol; 2010 Dec; 8(6):714-26. PubMed ID: 21158686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents.
    Scherer D; Hassel D; Bloehs R; Zitron E; von Löwenstern K; Seyler C; Thomas D; Konrad F; Bürgers HF; Seemann G; Rottbauer W; Katus HA; Karle CA; Scholz EP
    Br J Pharmacol; 2009 Jan; 156(2):226-36. PubMed ID: 19154426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lidoflazine is a high affinity blocker of the HERG K(+)channel.
    Ridley JM; Dooley PC; Milnes JT; Witchel HJ; Hancox JC
    J Mol Cell Cardiol; 2004 May; 36(5):701-5. PubMed ID: 15135665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
    Wiśniowska B; Mendyk A; Fijorek K; Glinka A; Polak S
    J Appl Toxicol; 2012 Oct; 32(10):858-66. PubMed ID: 22761000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The anti-addiction drug ibogaine and the heart: a delicate relation.
    Koenig X; Hilber K
    Molecules; 2015 Jan; 20(2):2208-28. PubMed ID: 25642835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. H(1) antihistamine drug promethazine directly blocks hERG K(+) channel.
    Jo SH; Hong HK; Chong SH; Lee HS; Choe H
    Pharmacol Res; 2009 Nov; 60(5):429-37. PubMed ID: 19497368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of HERG cardiac K+ current by antifungal drug miconazole.
    Kikuchi K; Nagatomo T; Abe H; Kawakami K; Duff HJ; Makielski JC; January CT; Nakashima Y
    Br J Pharmacol; 2005 Mar; 144(6):840-8. PubMed ID: 15778703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.